Edition:
NIAID Funding News provides funding, policy, and other information to NIAID's extramural research community and Institute staff. You can subscribe directly by entering your email address at Email Updates and then selecting your subscription topics. Visit Stay Informed About Policy Changes and News for more opportunities to connect with us.
Get To Know NIAID Small Business Programs
Our small business grant and contract funding opportunities help bridge the gap between basic science and commercialization of new therapies, vaccines, diagnostic tests, and other technologies.
Opportunities and Resources
NIAID has an ongoing and significant interest in supporting new vaccine adjuvants. Learn about the latest funding opportunities and a resource for querying adjuvant information.
Conduct fundamental research to identify potential shared signaling pathways and targets that may inform the development of broad-spectrum medical countermeasures.
NIAID anticipates making two cost-reimbursement type level-of-effort contracts to implement the Centers for Research on Structural Biology of Infectious Diseases program.
NIAID will support research to design and evaluate strategies for reducing HIV incidence by scaling up pre-exposure prophylaxis (PrEP) and antiretroviral treatment (ART) in sexually transmitted infections (STI) service settings.
In The News
NIAID Director Dr. Anthony Fauci discussed topics like budget and legislation, and Dr. John Mascola, director of the Vaccine Research Center (VRC), described VRC's work on mRNA and therapeutic antibodies related to COVID-19 as well as on influenza vaccines.
A new funding opportunity announcement (FOA) will fund multiple research centers focused on innovative antiviral drug development targeting coronaviruses and one or more select RNA viruses with pandemic potential.
NIH's Advisory Committee to the Director (ACD) provides recommendations for program development, resource allocation, NIH administrative regulation and policy, and other specific or general aspects of NIH policy.
Advice Corner
Biosafety in Microbiological and Biomedical Laboratories is an advisory document recommending best practices for safely conducting work in biomedical and clinical laboratories from a biosafety perspective.
Contact Us
Email us at deaweb@niaid.nih.gov for help navigating NIAID’s grant and contract policies and procedures.